Saurabh Srivastava

Dr. Saurabh Srivastava

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of Maxillofacial and Oral Surgery
Verified
Journal Article
Closed access
PDF file
SSSaurabh Srivastava
Saurabh Srivastava
SMShadab Mohammad
Shadab Mohammad
APAditya Bhushan Pant
Aditya Bhushan Pant
PMPrabhat Ranjan Mishra
Prabhat Ranjan Mishra
GPGitu Pandey
Gitu Pandey
SFSana Farooqui
Sana Farooqui

1 January 2018 in National Journal of Maxillofacial Surgery
Verified
Journal Article
Open access
PDF file
SSSaurabh Srivastava
Saurabh Srivastava
SMShadab Mohammad
Shadab Mohammad
SGShalini Gupta
Shalini Gupta
AMAbbas Ali Mahdi
Abbas Ali Mahdi
RDRakesh Kumar Dixit
Rakesh Kumar Dixit
FSFahad Mansoor Samadi
Fahad Mansoor Samadi
Introduction: Cancer of oral cavity is the uncontrolled expansion of damaged cell within the mouth cavity. 5-fluorouracil (5-FU) chemotherapy was focused to kill the cancer cell, but it would affect the surrounding normal cells during oral cancer treatment. This study included the evaluation of chemoprotective effects of curcumin (CU), as an herbal remedy, on 5-FU-induced-cytotoxicity toward oral cancer treatment, loaded within a nanocarrier system. CU was combined with 5-FU chemotherapy as a combinational drug-delivery system to evaluate synergistic effects. Materials and Methods: Nanoformulation of CU (nano-CU) and nanoformulation of 5-FU (nano-FU) were prepared by employing homogenization with high-energy sonication. The characterizations of prepared nanoformulations were evaluated on the basis of particle size, zeta potential, and polydispersity index (PDI) values. The chemopreventive effect of nano-CU on 5-FU induced-toxicity and synergistic efficacy were optimized through different in-vitro assays. Results: The average particle size of nano-CU and nano-FU were up to 200 nm, negatively-charged, and shown up to 4th-day control release of the drug within the acceptable concentration. IC50 value for growth inhibition was calculated as 47.89 and 26.19 μg/ml, respectively, for nano-CU and nano-FU. OCC was pretreated with nano-CU and shown the protective effect by reducing 5-FU induced-cytotoxicity by preventing normal cells through reduced viability. The DPPH-indicated fluorescence-tagged cells had quantified for antioxidant effect as it reduces intracellular reactive oxygen species level in OCC. Along with alteration in cell protein expression, Blc2, and Bax, shows enhanced apoptosis rate in OCC. Conclusion: Nano-CU provides chemoprotective nature towards 5-FU induced-toxicity, along with synergistic effects in oral cancer treatment.

15 April 2016 in Journal of Genetics
Verified
Journal Article
Closed access
PDF file
SHSyed Rizwan Hussain
Syed Rizwan Hussain
AMAbbas Ali Mahdi
Abbas Ali Mahdi
HNHena Naqvi
Hena Naqvi
MAMohammad Waseem Ahmad
Mohammad Waseem Ahmad
SSSaurabh Srivastava
Saurabh Srivastava
SGShalini Gupta
Shalini Gupta

3 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
IAIrfan Ahmad
Irfan Ahmad
SISafia Irfan
Safia Irfan
MAMohammad Mahtab Alam
Mohammad Mahtab Alam
SWShadma Wahab
Shadma Wahab
SSShahabe Saquib
Shahabe Saquib
NMNasrin Mansuri
Nasrin Mansuri
Background: The red-complex bacteria are one of the most significant complexes found simultaneously in subgingival plaque next to the periodontal pocket. The current antibacterial treatment is not adequate, and multidrug resistance to it is developing. Henceforth, the antibacterial effect of the ethanolic extract of Nepeta deflersiana was put to test against red-complex bacteria in patients with chronic periodontitis. Methods: Well diffusion and micro broth dilution procedure by Alamar blue were applied to assess the zone of inhibition (ZOI), the minimum inhibitory concentration (MIC), and the minimum bactericidal concentration (MBC). Anti-virulence efficacies of the plant extract that comprise of adherence and formation of biofilms were examined by the process of adherence and biofilm production assay. Results: The crude extract of Nepeta deflersiana exhibited significant inhibitory outcome against periodontopathic bacteria with noteworthy MIC (0.78–3.12 mg/mL), inhibitory zone (12–20 mm), as well as MBC (3.12–12.50 mg/mL). The N. deflersiana extract inhibited bacterial adhesion ranging from 41% to 52%, 53% to 66%, and 60% to 79% at the given MIC × 0.5, MIC × 1, and MIC × 2 in succession. Substantial suppression was also developed in the biofilm production of the investigated periodontopathic strains following exposure to numerous concentrations of N. deflersianan extract for a period of 24 and 48 h. Conclusion: These outcomes divulge a new concept that N. deflersiana extract can be utilized to manufacture valuable antibacterial compounds to treat chronic and acute periodontitis. This identifies N. deflersiana as an essential natural source for future drug development.

2 April 2022 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
RKRama Kashikar
Rama Kashikar
AKArun K. Kotha
Arun K. Kotha
SSSaurabh Shah
Saurabh Shah
PFParas Famta
Paras Famta
SSS Singh
S Singh
MCMahavir Bhupal Chougule
Mahavir Bhupal Chougule

25 September 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SKSuraj Kumar
Suraj Kumar
RMRishabh Malviya
Rishabh Malviya
SSSaurabh Srivastava
Saurabh Srivastava
CTChing Siang Tan
Ching Siang Tan
MAMohammad Y. Alshahrani
Mohammad Y. Alshahrani